Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2011, Article ID 670581, 4 pages
http://dx.doi.org/10.1155/2011/670581
Case Report

Acral Lentiginous Melanoma: A Case Control Study and Guidelines Update

1Department of Surgery, Interbalkan European Medical Center, 84 Tsimiski Street, 54622 Thessaloniki, Greece
2Department of Radiology, “Panagia” General Hospital, 22 Nik. Plastira street, Nea Krini, Kalamaria, 55132 Thessaloniki, Greece
3Department of Oncology, Interbalkan European Medical Center, 10 Asklipiou street, Pylaia, 57001 Thessaloniki, Greece

Received 11 October 2010; Accepted 15 February 2011

Academic Editor: Ting Fan Leung

Copyright © 2011 Christoforos Kosmidis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and M. J. Thun, “Cancer statistics, 2009,” CA Cancer Journal for Clinicians, vol. 59, no. 4, pp. 225–249, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. D. S. Rigel and J. A. Carucci, “Malignant melanoma: prevention, early detection, and treatment in the 21st century,” CA Cancer Journal for Clinicians, vol. 50, no. 4, pp. 215–236, 2000. View at Google Scholar · View at Scopus
  3. R. Reed, “Acral lentiginous melanoma,” in New Concepts in Surgical Pathology of the Skin, W. Hartmann and R. Reed, Eds., pp. 89–90, John Wiley & Sons, New York, NY, USA, 1976. View at Google Scholar
  4. D. A. Hudson, J. E. J. Krige, and H. Stubbings, “Plantar melanoma: results of treatment in three population groups,” Surgery, vol. 124, no. 5, pp. 877–882, 1998. View at Google Scholar · View at Scopus
  5. “National Comprehensive Cancer Network Practice Guidelines in Oncology,” http://www.nccn.org.
  6. C. M. Balch, S.-J. Soong, T. Smith et al., “Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas,” Annals of Surgical Oncology, vol. 8, no. 2, pp. 101–108, 2001. View at Publisher · View at Google Scholar
  7. S. Hansen, S. Mathes, and D. Young, “Skin and subcutaneous tissue,” in Schwartz’s Principles of Surgery, F. C. Brunicardi, D. K. Andersen, T. R. Billiar, D. L. Dunn, J. G. Hunter, and R. E. Pollock, Eds., pp. 1297–1315, McGraw-Hill, New York, NY, USA, 8th edition, 2005. View at Google Scholar
  8. D. G.. Coit, “Extent of groin dissection for melanoma,” Surgical Clinics of North America, vol. 1, pp. 271–280, 1992. View at Google Scholar
  9. D. G. Coit and M. F. Brennan, “Extent of lymph node dissection in melanoma of the trunk or lower extremity,” Archives of Surgery, vol. 124, no. 2, pp. 162–166, 1989. View at Google Scholar · View at Scopus
  10. P. Shen, A. M. Conforti, R. Essner, A. J. Cochran, R. R. Turner, and D. L. Morton, “Is the node of Cloquet the sentinel node for the iliac/obturator node group?” Cancer Journal, vol. 6, no. 2, pp. 93–97, 2000. View at Google Scholar · View at Scopus
  11. T. M. D. Hughes, R. P. A'Hern, and J. M. Thomas, “Prognosis and surgical mananagement of patients with palpable inguinal lymph node metastases from melanoma,” British Journal of Surgery, vol. 87, no. 7, pp. 892–901, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. M. M. Urist and S. J. Soong, “Melanoma and cutaneous malignancies,” in Sabiston Textbook of Surgery, The Biological Basis of Modern Surgical Practice, C. M. Townsend, R. D. Beauchamp, B. M. Evers, and K. L. Mattox, Eds., pp. 767–785, WB Saunders, Philadelphia, Pa, USA, 18th edition, 2008. View at Google Scholar
  13. J. F. Thompson and H. M. Shaw, “The prognosis of patients with thick primary melanomas: is regional lymph node status relevant, and does removing positive regional nodes influence outcome?” Annals of Surgical Oncology, vol. 9, no. 8, pp. 719–722, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. Clary, M. S. Brady, J. J. Lewis, and D. G. Coit, “Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence,” Current Surgery, vol. 60, no. 1, pp. 16–20, 2003. View at Google Scholar
  15. S. Dessureault, S. J. Soong, M. I. Ross et al., “Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy,” Annals of Surgical Oncology, vol. 8, no. 10, pp. 766–770, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. D. L. Morton, A. J. Cochran, J. F. Thompson et al., “Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial,” Annals of Surgery, vol. 242, no. 3, pp. 302–313, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. D. L. Morton, J. F. Thompson, A. J. Cochran et al., “Sentinel-node biopsy or nodal observation in melanoma,” The New England Journal of Medicine, vol. 355, no. 13, pp. 1307–1317, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. M. Johnson, V. K. Sondak, C. K. Bichakjian, and M. S. Sabel, “The role of sentinel lymph node biopsy for melanoma: evidence assessment,” Journal of the American Academy of Dermatology, vol. 54, no. 1, pp. 19–27, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. B. M. Clary, M. S. Brady, J. J. Lewis, and D. G. Coit, “Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence,” Annals of Surgery, vol. 233, no. 2, pp. 250–258, 2001. View at Publisher · View at Google Scholar · View at Scopus